Disclosure of clinically actionable genetic variants to thoracic aortic dissection biobank participants

RT @cristenw: @BrentRichards19 @Eric_Fauman @ZhaoDylan The process is described in this publication, including copies of the letters we sen…

@BrentRichards19 @Eric_Fauman @ZhaoDylan The process is described in this publication, including copies of the letters we send to the physician and patient (followed by a phone call) etc. https://t.co/ifI3hOQ89g

@Eric_Fauman In the Beil paper, we detail the pipeline we developed to return research-grade (non-CLIA) results, and a survey of the (~10) people who received results: they reported low stress levels (decision regret of 11.5 out of 100 and FACToR distress

RT @cristenw: This is the IRB-approved pipeline we built to return research-level (not clinical grade/CLIA) genetic results to research par…